UK markets closed

Legend Biotech Corporation (LEGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
45.16-1.21 (-2.61%)
At close: 04:00PM EDT
46.20 +1.04 (+2.30%)
After hours: 05:39PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
342,798
285,143
117,005
68,826
75,000
Cost of revenue
163,340
144,214
65,363
0
0
Gross profit
179,458
140,929
51,642
68,826
75,000
Operating expenses
Research development
398,293
382,218
335,648
313,346
232,160
Selling general and administrative
216,920
200,927
174,048
149,503
72,705
Total operating expenses
612,576
580,414
507,262
461,113
301,793
Operating income or loss
-433,118
-439,485
-455,620
-392,287
-226,793
Interest expense
22,156
21,794
10,796
900
195
Total other income/expenses net
-74,261
-113,326
12,510
-14,980
-80,213
Income before tax
-467,933
-520,118
-445,724
-407,196
-308,285
Income tax expense
-1,987
-1,864
625
-3,614
-41,912
Income from continuing operations
-465,946
-518,254
-446,349
-403,582
-266,373
Net income
-465,946
-518,254
-446,349
-403,582
-266,373
Net income available to common shareholders
-465,946
-518,254
-446,349
-403,582
-266,373
Basic EPS
-2.96
-2.94
-2.80
-2.86
-2.26
Diluted EPS
-2.96
-2.94
-2.80
-2.86
-2.26
Basic average shares
171,867
176,083
159,042
140,852
118,153
Diluted average shares
171,867
176,083
159,042
140,852
118,153